# Molina Healthcare Inc (MOH) fundamentals

Data as of 2026-09-08. NYSE, United States. Sector: Healthcare / Health Care Providers & Services. Price $200.80, market value $10.5 billion.

## Valuation
- **P/E (trailing): 1255.0×** (5-yr avg 21.1×, 3-yr avg 17.7×). Molina Healthcare Inc trades at 1255.0× trailing earnings, well above its own five-year average of 21.1×: investors are paying up relative to the company's past. The Healthcare median in the September 2026 study was 28.5×. Forward P/E is 20.6×, lower than trailing, so analysts expect earnings to grow.
- **Price / sales: 0.2×**. Each dollar of revenue is priced at 0.2×, a low multiple typical of thin-margin businesses or out-of-favour stocks.
- **Price / book: 2.5×**. The shares trade at 2.5× book value; book value is a meaningful part of the valuation.
- **EV / EBITDA: 27.0×**. Enterprise value is 27.0× operating earnings before depreciation, the multiple that ignores how the company is financed; above 20× is demanding.
- **Free-cash-flow yield: 2.6%** (5-yr avg 3.7%). Free cash flow equals 2.6% of the market value, below its five-year average of 3.7%, so the shares are pricier on cash than usual.
- **Earnings yield: 0.1%**. The inverse of the P/E: 0.1% of the price is earned each year.

## Profitability
- **Operating margin: 0.5%**. 0.5% of revenue is left after running the business, which leaves little cushion in a downturn.
- **Net margin: 1.0%**. 1.0% of each dollar of sales reaches the bottom line.
- **Return on equity: 11.6%**. 11.6% on shareholders' equity is solid.
- **Return on invested capital: 4.5%**. Return on all capital, debt included, is 4.5%: close to or below the cost of capital, so growth may not create value.
- **Return on assets: -0.0%**. Each dollar of assets produces -0.0% of profit.

## Growth
- **Revenue growth (1 yr): 11.7%** (3-yr 12.4%/yr, 5-yr 18.5%/yr). Revenue grew 11.7% over the last year, against 18.5% a year compounded over five years: growth is slowing.
- **EPS growth (1 yr): -56.3%** (3-yr -13.0%/yr, 5-yr -4.5%/yr). Earnings per share fell 56.3%, slower than revenue, so margins compressed.

## Financial health
- **Debt to equity: 0.93**. Debt is 0.93 times equity, moderate leverage.
- **Net debt / EBITDA: net cash**. Molina Healthcare Inc holds more cash than debt.
- **Altman Z-score: 4.00**. A Z-score of 4.00 places the company in the safe zone for bankruptcy risk.
- **Piotroski F-score: 3/9**. 3 of 9 checks pass: weak or deteriorating financials.

## Dividends
- **Dividend: none**. Molina Healthcare Inc does not currently pay a dividend.

## Analyst view
- **Analyst consensus: hold** (17 analysts). 17 analysts cover Molina Healthcare Inc; the consensus is hold, with an average price target of $209.12 (+4% from the current price). Analyst opinion is shown for context; it is not part of the Fundamental Score.

## Price and momentum
- **Total return (1 yr): 17.5%** (YTD 15.7%, 3-mo 5.2%). The shares are up 17.5% over twelve months including dividends.
- **From 52-week high: -18.0%** (65.9% above the low). Trading 18% below its 52-week high.
- **200-day average: above**. The price sits above its 200-day moving average, the usual definition of an uptrend.
- **RSI (14-day): 48**. An RSI of 48 is neutral.
- **Beta (1 yr): -0.12** (volatility 53%). Beta of -0.12 against the S&P 500: the shares move much less than the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=MOH · Page: https://foliofundamentals.com/stocks/moh

Not investment advice.